静脉注射埃斯莫洛尔和口服克洛尼丁之间的比较研究,以减轻对喉腔镜和内管道输入术的高动态心血管反应
V N K Srinivas Mudiganti1,2, Brig Tvsp Murthy3,4,5, Sneha Kakara6
1Critical Care Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Acharya Vinoba Bhave Rural Hospital (AVBRH), Wardha, IND.
静脉注射埃斯莫洛尔在麻醉诱导期间有效抑制了血液动力学反应,与口服克洛尼丁或安慰剂相比,在心率和血压上提供了更好的控制.
科学领域:
- 麻醉学 麻醉学
- 心血管药理学心血管药理学
背景情况:
- 均衡的麻醉对于患者护理和疼痛管理至关重要.
- 在麻醉诱导期间,血液动力学稳定性至关重要,特别是对于喉腔镜检查的反应.
- 前期药物治疗策略旨在减轻输管治疗的高血压和心跳动效应.
研究的目的:
- 为了比较静脉注射埃斯莫洛尔与口服克洛尼丁作为抑制麻醉诱导期间血液动力学反应的前期药物的疗效.
- 评估这些药物对血压和心率波动的影响.
主要方法:
- 一项前性随机对照试验,涉及90名患者.
- 患者被分为三个组:静脉注射埃斯莫洛尔,口服克洛尼丁和安慰剂.
- 血液动力学参数 (血压,心率,平均动脉压) 在基线和诱导后7分钟内被测量.
主要成果:
- 静脉注射埃斯莫洛尔显示了平均动脉压和缩血压的持续下降.
- 与克洛尼丁和安慰剂组相比,埃斯莫洛尔组显示出对血液动力学参数的优越控制.
- 口服克洛尼丁比安慰剂降低了透析血压,但两者都显示出比埃斯莫洛尔更可变的反应.
结论:
- 静脉注射埃斯莫洛尔在麻醉诱导期间提供有效和快速的血液动力学控制.
- 与口服克洛尼丁相比,埃斯莫洛尔可以更好地抑制喉镜的高血压反应.
- 埃斯莫洛尔是一种有价值的前期治疗选择,可以保持血液动力学稳定.
更多相关视频
05:39Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
07:22Minimally Invasive Murine Laryngoscopy for Close-Up Imaging of Laryngeal Motion During Breathing and Swallowing
Published on: December 1, 2023
相关概念视频
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Skeletal Muscle Relaxants: Therapeutic Uses
Drug Delivery: Enteral Route
